Oops!
An unfortunate error occurred at Emergent BioSolutions Company's plant in Baltimore, USA.
Enlisted to produce vaccines for both Johnson & Johnson and AstraZeneca, the company has, according to the American press, tangled the brushes by mixing the ingredients of the two serums.
Emergent does not confirm the nature of the problem but agrees that it had to destroy a batch.
Fifteen million doses have gone in the trash.
We learn, through this story of waste, that Washington had reserved production capacities at Emergent even before knowing which vaccine would be put on the market.
The contract between the company and the US government was concluded on May 30, 2020, for an amount of $ 628 million.
By way of comparison, Delpharm, which starts bottling for Pfizer / BioNTech on Wednesday, was “hired” in mid-November 2020.
Central scenario
This is the
"madness"
that Europe has lacked, to use the words of Emmanuel Macron.
In
This article is for subscribers only.
You have 79% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in